Challenges in Developing Biosimilars.

-


12th European Biosimilars Congress 2019 Jsbconference invites you to attend the largest assemblage of biologics and biosimilars researchers from around the globe during April 15-16, 2019 at Berlin, Germany
. 
European Biosimilars Congress is a global annual event. This Biosimilars Congress 2019 brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of Biosimilars through a decade at Asia finds much requirement for discussion also focusing the Current Challenges in Developing Biosimilars. International World Conference

CONFERENCE HIGHLIGHTS 

• Current Challenges in Developing Biosimilars 
• Analytical Strategies for Biosimilars 
• Intellectual Property Rights 
• Biological Medicine 
• Emerging Biosimilars in Therapeutics 
• Innovative Clinical Approach in Biosimilars 
• Regulatory Updates on Biosimilars 
• Biosimilars Development in Markets 
• Biosimilars Approval to Biogenerics in Clinical Practice 
• Biopharmaceutical Informatics 
• Consequences of Brexit on Biosimilars 
• BCS and IVIVC Based Biowaivers 
• Biosimilars Market and Cost Analysis 
• Challenges in Biosimilars Pharmacovigilance 
• Legal Issues and BPCI Act 
• Formulation Strategies for Follow-on Biologics 
• Current Agency Expectations for Approval for Biosimilars 
• Biosimilars Research Pipeline 
• Globalization of Biosimilars 
• Drug Delivery and Development 
• Monoclonal Antibody Biosimilars 
• USFDA Approved Biosimilars 

For More Information - 
JSB Conference Events team 
Mobile: +91 9987295242 
Email: support@jsbconference.com 
support@jsbconference.com

Comments

Post a Comment

Popular posts from this blog

Nanotech Changing life Forms at a Molecular Level

-
Image
The world has been into some of the deadliest biological threats in the current decade. Science has manifested several new processes that can be attempted to save slightest of the pathogenic disasters. Consequently, Nanotechnology is one such domain that makes an attempt in the biological realm. It predominantly refers to the combined process of nanotechnology and biology. The former largely has been used in the manner of using devices that can penetrate at a much smaller level, and when combined to biology it becomes a relatively usable technology. International World Conferences across the world are in the process of implementing and discussing aspects of Nanobiotechnology. The upcoming Conference in Europe , the Netherlands demonstrates beneficial aspects for the technology. What is Nanobiotechnology? Nanobiotechnology has categories that fulfill the need for relevant nanotools that can cure medical as well as biological problems. Furthermore, several processes are bei
Read more

A life & Career of a Cardiologists

-
Image
Cardiologist’s life at a Glance: Know more about it. A cardiologist is described as a doctor who specializes with special training and skills in finding, treating and preventing diseases of heart and blood vessels. Cardiologists Conference 2019 is an upcoming international cardiology conference to be held in Italy. It focuses on key aspects of the domain and its subsequent uses involved around heart diseases. Cardiologists vary from country to country based on the preferences they have on treatment. Consequently, credentials, achievements and community contributions to various cardiovascular medicines, physicians across the globe are elected to perform fellowship under professional designation. Usually, hypertension is also one of the health condition related to health and is defined as blood pressure above 140/90, and is considered severe if the pressure is above 180/120. High blood pressure often has no symptoms. Over time, if untreated, it can cause health conditions,
Read more

International Conference on HPAPI World Congress 2018 Switzerland

-
Image
We JSBCONFERENCE invite you for an upcoming conference on HPAPI World Congress 2018 which will be held on 30-31 October 2018 in  Basel, Switzerland. As part of the Festival of Biologics, the HPAPI World Congress will be co-located with World Biosimilar Congress,  World Immunotherapy Congress, and European Antibody Congress. Attendees will have access to plenty of content across the 3 days and more networking opportunities than ever before with over 800+ leading industry professionals. The HPAPI World Congress has been developed over 4 years as the only two tracked HPAPI Congress. The event has a strong focus on the management of HPAPI, Design of Facilities, Innovation of New HPAPI’s, SHE, Working with CMOs and case studies. We have a diverse group of companies and consultants along with a mix of different formats to provide the best possible learning experience for our participants. We will be presenting many first releases on the event including understanding a new class of ADC
Read more